Bright Green Corp financial data

Symbol
BGXX on OTC
Industry
Medicinal Chemicals & Botanical Products
Location
401 East Las Olas Blvd., Suite 1400, Ft. Lauderdale, FL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.12 % -63.9%
Debt-to-equity 59.8 % -28.8%
Return On Equity -88.4 % -20.6%
Return On Assets -55.3 % -38.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 191M shares +3.96%
Common Stock, Shares, Outstanding 191M shares +3.96%
Entity Public Float 75.1M USD -47.1%
Common Stock, Value, Issued 19.1K USD +3.97%
Weighted Average Number of Shares Outstanding, Basic 191M shares +5.77%
Weighted Average Number of Shares Outstanding, Diluted 191M shares +5.77%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
General and Administrative Expense 5.4M USD -35.6%
Operating Income (Loss) -5.99M USD +33.7%
Nonoperating Income (Expense) 7.83K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.99M USD +2.81%
Net Income (Loss) Attributable to Parent -9.03M USD +5.7%
Earnings Per Share, Basic -0.05 USD/shares +16.7%
Earnings Per Share, Diluted -0.05 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 52.3K USD -81.2%
Property, Plant and Equipment, Net 15.9M USD -16.9%
Intangible Assets, Net (Excluding Goodwill) 9.01K USD +801%
Assets 16M USD -34.4%
Accounts Payable, Current 5.38M USD -9.29%
Accrued Liabilities, Current 59.9K USD -94.8%
Liabilities, Current 7.04M USD -19.3%
Liabilities 7.04M USD -19.3%
Retained Earnings (Accumulated Deficit) -50.7M USD -21.7%
Stockholders' Equity Attributable to Parent 8.92M USD -42.9%
Liabilities and Equity 16M USD -34.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -58.6K USD -121%
Net Cash Provided by (Used in) Financing Activities 110K USD -91.4%
Net Cash Provided by (Used in) Investing Activities -61.5K USD +96%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 191M shares +3.96%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.1K USD -227%
Deferred Tax Assets, Valuation Allowance 11.1M USD +38.6%
Deferred Tax Assets, Gross 11.1M USD +38.6%
Depreciation 594K USD -9.32%
Payments to Acquire Property, Plant, and Equipment 56.1K USD -96.5%
Property, Plant and Equipment, Gross 19.8M USD -11.8%
Deferred Tax Assets, Operating Loss Carryforwards 9.72M USD +33.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 15K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%